Clinacuity has been selected to participate in the biennial NIH Commercialization Accelerator Program (CAP) for 2017-2018, an excellent opportunity for our company!
The CAP is designed to help NIH technology transfer funding awardees transition their SBIR/STTR developed products into the marketplace through a contract with Larta Inc.
It will provide companies with individualized assistance toward accomplishing their commercialization goals.